Acute respiratory distress syndrome (ARDS) is characterised by acute hypoxaemic
respiratory failure with bilateral infiltrates on chest imaging, which is not fully explained by …

More than 125 million confirmed cases of COVID-19 have been reported globally with rising
cases in all countries since the first case was reported. A vaccine is the best measure for the …

Patients with hematologic malignancies and recipients of hematopoietic cell transplantation
(HCT) are more likely to experience severe coronavirus disease 2019 (COVID-19) and have …

The coronavirus disease 2019 (COVID-19) pandemic has posed unprecedented challenges
in critical care medicine, including extreme demand for intensive care unit (ICU) resources …

Acute respiratory distress syndrome (ARDS) is a severe form of respiratory failure burden by
high hospital mortality. No specific pharmacologic treatment is currently available and its …

Comparing Prone Positioning Use in COVID-19 Versus Historic... : Critical Care
Explorations Comparing Prone Positioning Use in COVID-19 Versus Historic Acute …

Importance Early observations suggested that COVID-19 pneumonia had a higher mortality
rate than other causes of pneumonia. Objective To compare outcomes between …

Introduction Acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019
(COVID-19) often leads to mortality. Outcomes of patients with COVID-19-related ARDS …

Data regarding the use of corticosteroids for treatment of acute respiratory distress syndrome
(ARDS) are conflicting. As the coronavirus disease 2019 (COVID‐19) pandemic progresses …

The pathophysiology of coronavirus disease-2019 (COVID-19)-related acute respiratory
distress syndrome (ARDS) varies from other pneumonia-related ARDS. We evaluated …